Targeted nanomedicine for detection and treatment of circulating tumor cells

Nanomedicine

Volumn 6, Issue 4, 2011, Pages 579-581

  Muthu, Madaswamy S ^a,b   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

active targeting; cancer; circulating tumor cell; in vivo diagnosis; metastasis; theranostic

Indexed keywords

CARBON NANOTUBE; EPITHELIAL CELL ADHESION MOLECULE; FLUORESCENT DYE; FOLATE RECEPTOR; HERMES ANTIGEN; NANOCARRIER; NANOPARTICLE;

BLOOD VOLUME; CANCER DIAGNOSIS; CANCER STAGING; CANCER THERAPY; CIRCULATING TUMOR CELL; FLOW CYTOMETRY; HUMAN; IN VIVO STUDY; MACROPHAGE; METASTASIS; NANOMEDICINE; NONHUMAN; PHOTOACOUSTIC SPECTROSCOPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SENSIBILITY; SOLID TUMOR;

FLOW CYTOMETRY; HUMANS; NANOMEDICINE; NANOTECHNOLOGY; NEOPLASTIC CELLS, CIRCULATING;

EID: 79959971875     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.17     Document Type: Review

References (16)

1. Feng SS: Nanoparticles of biodegradable polymers for new concepts chemotherapy. Expert Rev. Med. Devices 1, 115-125 (2004).
2. Weissleder R, Pittet MJ: Imaging in the era of molecular oncology. Nature 452, 580-589 (2008). (Pubitemid 351483372)
3. Muthu MS, Rajesh CV, Mishra A, Singh S: Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomedicine (Lond.) 4, 657-667 (2009).
4. Bawarski WE, Chidlowsky E, Bharali DJ, Mousa SA: Emerging nanopharmaceuticals. Nanomedicine 4, 273-282 (2008).
5. Muthu MS, Singh S: Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine (Lond.) 4, 105-118 (2009).
6. Georgakoudi I, Solban N, Novak J, et al.: In vivo flow cytometry: a new method for enumerating circulating cancer cells. Cancer Res. 64, 5044-5047 (2004). (Pubitemid 39006514)
7. Kaiser J: Cancers circulation problem. Science 327, 1072-1074 (2010).
8. Nagrath S, Sequist LV, Maheswaran S, et al.: Isolation of rare circulating tumor cells in cancer patients by microchip technology. Nature 450, 1235-1239 (2007).
9. Galanzha EI, Shashkov EV, Spring PM, et al.: In vivo, noninvasive, label-free detection and eradication of circulating metastatic melanoma cells using two-color photoacoustic flow cytometry with a diode laser. Cancer Res. 69, 7926-7934 (2009).
10. Galanzha EI, Kokoska MS, Shashkov EV, et al.: In vivo fiber-based multicolor photoacoustic detection and photothermal purging of metastasis in sentinel lymph nodes targeted by nanoparticles. J. Biophoton. 2, 528-539 (2009).
11. Galanzha EI, Kim J-W, Zharov VP: Nanotechnology-based molecular photoacoustic and photothermal flow cytometry platform for in-vivo detection and killing of circulatory cancer stem cells. J. Biophoton. 2, 725-735 (2009).
12. Galanzha EI, Shashkov EV, Kelly T, et al.: In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumor cells. Nat. Nanotech. 4, 855-860 (2009).
13. Zharov VP, Galanzha EI, Shashkov EV, et al.: In vivo photoacoustic flow cytometry for monitoring of circulating single cancer cells and contrast agents. Opt. Lett. 31, 3623-3625 (2006). (Pubitemid 46079723)
14. McCarthy JR: The future of theranostic nanoagents. Nanomedicine (Lond.) 4, 693-695 (2009).
15. Sumer B, Gao J: Theranostic nanomedicine for cancer. Nanomedicine (Lond.) 3, 137-140 (2008). (Pubitemid 351611851)
16. Muthu MS, Feng SS: Pharmaceutical stability aspects of nanomedicines. Nanomedicine (Lond.) 4, 857-860 (2009).